{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:26:12Z","timestamp":1780514772427,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"UNC Oncology Clinical Translational Research Training Program","award":["K12 CA120780"],"award-info":[{"award-number":["K12 CA120780"]}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","gastrojournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1053\/j.gastro.2017.10.042","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T21:30:56Z","timestamp":1510003856000},"page":"861-873.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002\u20132014)"],"prefix":"10.1053","volume":"154","author":[{"given":"Suzanne N.","family":"Landi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Pate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2017.10.042_bib1","series-title":"Medicines use and spending shifts","year":"2015"},{"issue":"2 Suppl 1","key":"10.1053\/j.gastro.2017.10.042_bib2","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0016-5085(00)70004-7","article-title":"Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome","volume":"118","author":"Wolfe","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.10.042_bib3","doi-asserted-by":"crossref","first-page":"859","DOI":"10.7326\/0003-4819-124-10-199605150-00001","article-title":"Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole. A randomized, double-blind, placebo-controlled trial","volume":"124","author":"Robinson","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2017.10.042_bib4","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199510263331703","article-title":"A\u00a0comparison of five maintenance therapies for reflux esophagitis","volume":"333","author":"Vigneri","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2017.10.042_bib5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: expert review\u00a0and best practice advice from the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.10.042_bib6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1365-2036.2005.02454.x","article-title":"Long-term use of\u00a0acid suppression started inappropriately during hospitalization","volume":"21","author":"Zink","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.10.042_bib7","series-title":"Prilosec: from prescription to OTC","year":"2014"},{"key":"10.1053\/j.gastro.2017.10.042_bib8","series-title":"Prescription to over-the-counter (OTC) switch list","year":"2015"},{"key":"10.1053\/j.gastro.2017.10.042_bib9","unstructured":"Nexium 24HR. About Nexium 24HR. New York, NY: Pfizer Inc., 2015. Available at: http:\/\/www.nexium24hr.com\/us\/about. Accessed April 24,\u00a02015."},{"key":"10.1053\/j.gastro.2017.10.042_bib10","unstructured":"Prevacid 24HR. About Prevacid 24HR. Basel, Switzerland: Novartis Consumer Health, Inc., 2015. Available at: https:\/\/www.prevacid24hr.com\/index.jsp?channel=search&page=underhb&smtoffers=trialps&cid=ps-20150416-usprevps2015fy-google-1brandgeneralotcexact-prevacidotc-exactmatch-ps20150416_1125. Accessed April 24,\u00a02015."},{"key":"10.1053\/j.gastro.2017.10.042_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.gastro.2017.04.047","article-title":"Complications of proton pump inhibitor therapy","volume":"153","author":"Vaezi","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.10.042_bib12","series-title":"Possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors","year":"2010"},{"key":"10.1053\/j.gastro.2017.10.042_bib13","series-title":"Information for healthcare professionals: update to\u00a0the labeling of clopidogrel bisulfate (marketed as Plavix) to alert healthcare professionals about a drug interaction with omeprazole (marketed as Prilosec and Prilosec OTC)","year":"2009"},{"key":"10.1053\/j.gastro.2017.10.042_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2007.06.064","article-title":"Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study","volume":"51","author":"Gilard","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1053\/j.gastro.2017.10.042_bib15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1160\/TH08-12-0808","article-title":"Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel","volume":"101","author":"Sibbing","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.gastro.2017.10.042_bib16","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2017.10.042_bib17","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.amjmed.2016.03.042","article-title":"Efficacy and safety of proton-pump inhibitors in high-risk cardiovascular subsets of the COGENT Trial","volume":"129","author":"Vaduganathan","year":"2016","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2017.10.042_bib18","doi-asserted-by":"crossref","first-page":"e0124653","DOI":"10.1371\/journal.pone.0124653","article-title":"Proton pump inhibitor usage and the risk of myocardial infarction in the general population","volume":"10","author":"Shah","year":"2015","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2017.10.042_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijcard.2014.09.036","article-title":"Proton pump inhibitor\u00a0use represents an independent risk factor for\u00a0myocardial infarction","volume":"177","author":"Shih","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.gastro.2017.10.042_bib20","doi-asserted-by":"crossref","first-page":"e84890","DOI":"10.1371\/journal.pone.0084890","article-title":"Proton pump inhibitors and the risk of adverse cardiac events","volume":"8","author":"Juurlink","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2017.10.042_bib21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.113.003602","article-title":"Unexpected effect of proton pump inhibitors: elevation of\u00a0the cardiovascular risk factor asymmetric dimethylarginine","volume":"128","author":"Ghebremariam","year":"2013","journal-title":"Circulation"},{"key":"10.1053\/j.gastro.2017.10.042_bib22","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical\u00a0trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.gastro.2017.10.042_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active\u00a0comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application","volume":"2","author":"Lund","year":"2015","journal-title":"Curr Epidemiol Rep"},{"key":"10.1053\/j.gastro.2017.10.042_bib24","series-title":"Health research data for the real world: the MarketScan databases","author":"Quint","year":"2015"},{"key":"10.1053\/j.gastro.2017.10.042_bib25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ije\/dyi060","article-title":"Proper interpretation of non-differential misclassification effects: expectations vs observations","volume":"34","author":"Jurek","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1053\/j.gastro.2017.10.042_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1740774511420743","article-title":"Beyond the intention to treat in comparative effectiveness research","volume":"9","author":"Hern\u00e1n","year":"2012","journal-title":"Clin Trials"},{"key":"10.1053\/j.gastro.2017.10.042_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/pds.3310","article-title":"Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program","volume":"22","author":"Cutrona","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1053\/j.gastro.2017.10.042_bib28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1525-1497.1999.10198.x","article-title":"Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database","volume":"14","author":"Petersen","year":"1999","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1053\/j.gastro.2017.10.042_bib29","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1475-6773.2012.01440.x","article-title":"Case definitions for acute myocardial infarction in administrative databases and their impact on in-hospital mortality rates","volume":"48","author":"Metcalfe","year":"2013","journal-title":"Health Serv Res"},{"key":"10.1053\/j.gastro.2017.10.042_bib30","series-title":"Pharmacoepidemiology","first-page":"561","article-title":"Comparative effectiveness research","author":"Strom","year":"2012"},{"key":"10.1053\/j.gastro.2017.10.042_bib31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/CIRCOUTCOMES.113.000359","article-title":"Propensity score methods for confounding control in nonexperimental research","volume":"6","author":"Brookhart","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1053\/j.gastro.2017.10.042_bib32","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States From 1999\u20132012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2017.10.042_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/CIRCOUTCOMES.111.962456","article-title":"Geographical disparities in the incidence and outcomes of hospitalized myocardial infarction: does a rising tide lift all boats?","volume":"5","author":"Yeh","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1053\/j.gastro.2017.10.042_bib34","doi-asserted-by":"crossref","first-page":"689531","DOI":"10.1155\/2015\/689531","article-title":"Brand name and generic proton pump inhibitor prescriptions in the United States: insights from the national ambulatory medical care survey (2006\u20132010)","volume":"2015","author":"Gawron","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"10.1053\/j.gastro.2017.10.042_bib35","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMp1006189","article-title":"Four-dollar generics\u2013increased accessibility, impaired quality assurance","volume":"363","author":"Choudhry","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2017.10.042_bib36","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/pds.3458","article-title":"Completeness of prescription information in US commercial claims databases","volume":"22","author":"Lauffenburger","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1053\/j.gastro.2017.10.042_bib37","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/01.ede.0000135174.63482.43","article-title":"A\u00a0structural approach to selection bias","volume":"15","author":"Hern\u00e1n","year":"2004","journal-title":"Epidemiology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508517363308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508517363308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T18:07:56Z","timestamp":1668622076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508517363308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0016508517363308"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2017.10.042","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002\u20132014)","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2017.10.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the AGA Institute","name":"copyright","label":"Copyright"}]}}